Menon M, Tananis C E, McLoughlin M G, Walsh P C
Cancer Treat Rep. 1977 Mar-Apr;61(2):265-71.
Methods for the measurements of androgen receptors in the human prostate have been reviewed. The differentiation of binding to receptor from binding to a contaminating serum protein, testosterone-estradiol binding globulin (TeBG), has been the major problem in the establishment of a reliable assay in man. Charcoal adsorption and Sephadex gel filtration (G-25) have been the simplest methods utilized, but unfortunately they do not eliminate binding to TeBG. Although other methods such as sucrose density gradient centrifugation, ion-exchange chromatography, and protamine precipitation are more specific for the measurement of the androgen receptor, they have not been uniformly reproducible and are too elaborate for easy clinical applicability. For clinical purposes, assays using potent synthetic androgens that do not bind to TeBG or anti-steroid antibodies may prove to be the methods utilized in the future to measure the androgen receptor content of human prostatic tissue.
对人前列腺中雄激素受体的测量方法进行了综述。将与受体的结合与与污染血清蛋白睾酮 - 雌二醇结合球蛋白(TeBG)的结合区分开来,一直是在人体中建立可靠检测方法的主要问题。活性炭吸附和葡聚糖凝胶过滤(G - 25)是使用过的最简单的方法,但不幸的是它们不能消除与TeBG的结合。尽管其他方法如蔗糖密度梯度离心、离子交换色谱和鱼精蛋白沉淀在雄激素受体测量方面更具特异性,但它们的重复性不一致,且过于复杂,难以轻松应用于临床。出于临床目的,使用不与TeBG结合的强效合成雄激素或抗类固醇抗体的检测方法可能会成为未来用于测量人前列腺组织中雄激素受体含量的方法。